4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-22-011518
President and CEO gave up 7,655 shares (to pay taxes)
- President and CEO acquired 2,757 shares (grant or award)
- President and CEO acquired 16,545 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Garg Vipin K · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-31 | Grant or award : show line 1 in the form | +2,757 | $6.86 | $18,913 | 283,958 | D |
| 2022-02-01 | Exercise or conversion : show line 2 in the form | +16,545 | 300,503 | D | ||
| 2022-02-01 | Shares withheld for taxes : show line 3 in the form | −7,655 | $7.98 | $61,087 | 292,848 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-01 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −16,545 | 49,636 | D |
| 2022-02-02 | Grant or award : show line 5 in the form Stock Options (option to buy) | +223,000 | 223,000 | D |
| 2022-02-02 | Grant or award : show line 6 in the form Restricted Stock Units | +75,800 | 75,800 | D |
Loading xslF345X03/tm225504-2_4seq1.xml…